Evgeny V Berdyshev

14PUBLICATIONS
68CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cellular interactions (incl. adhesion, matrix, cell wall)Cellular immunologyInfant and child healthEnvironmental epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 25, 2026
Skin Abnormalities at Checkpoint Inhibitor Therapy Initiation Are Associated With Skin Rash Development in Oncology Patients.

|Oct 04, 2024
Skin Lipid Barrier: Structure, Function and Metabolism.

Evgeny Berdyshev

|Apr 23, 2024
Immunologic Profiling of Immune-Related Cutaneous Adverse Events with Checkpoint Inhibitors Reveals Polarized Actionable Pathways.

Mario E Lacouture, Elena Goleva, Neil Shah

|Apr 06, 2023
Alterations of Epidermal Lipid Profiles and Skin Microbiome in Children With Atopic Dermatitis.

Jihyun Kim, Byung Eui Kim, Elena Goleva

|Jan 07, 2023
Staphylococcus aureus causes aberrant epidermal lipid composition and skin barrier dysfunction.

Jihyun Kim, Byung Eui Kim, Evgeny Berdyshev

|Jul 11, 2022
Dupilumab significantly improves skin barrier function in patients with moderate-to-severe atopic dermatitis.

Evgeny Berdyshev, Elena Goleva, Robert Bissonnette

Pageof 3

Frequent Collaborators

6 joint publications

Donald Y M Leung

6 joint publications

Elena Goleva

3 joint publications

Clifton F Hall

2 joint publications

Byung Eui Kim